NICE leads global shift: How health equity is influencing drug approvals

Home / Media Center / Trinity in the News / NICE leads global shift: How health equity is influencing drug approvals

Informa  |  April 3, 2025

Trinity Life Sciences’ Managing Director and Head of Value Center of Excellence, Mary Fletcher-Louis, spoke with Access Insider about how the UK’s National Institute for Health and Care Excellence (NICE) is spearheading a global shift in pharmaceutical decision-making by incorporating health equity considerations into drug submissions.